Doctor profile · Federal record
Dr. Kavita Seetharaman, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Internal Medicine Physician · Boston, MA
- NPI 1588608533
- Accepts Medicare
- 30 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
75 Francis St
Boston, MA 021156110
(617) 732-5500
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- October 24, 2025
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Massachusetts #220006
- Medicaid
- MA #2084741
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588608533. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
508
Distinct HCPCS
5
Medicare allowed
$63,853
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 279 | 207 | $140 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 91 | 54 | $37 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 61 | 61 | $182 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 45 | 42 | $99 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 32 | 29 | $186 |
In context: peer comparison
Among 97 peers in Boston Endocrinology, Diabetes & Metabolism Physician, average services per provider: 116. This provider delivers 4.4× the peer median.Open Payments
Industry payments received
All-time total
$31
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Stemline Therapeutics INC. | 1 | $31.22 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
932
Patients
316
Total drug cost
$661,402
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trulicity (Dulaglutide) | Brand | 160 | 41 | $314,652 |
| Metformin Hcl ER (Metformin Hcl) | Brand | 116 | 44 | $2,472 |
| Levothyroxine Sodium | Generic | 103 | 33 | $1,624 |
| Alendronate Sodium | Generic | 90 | 31 | $2,964 |
| Glipizide | Generic | 70 | 28 | $763 |
| Metformin Hcl | Generic | 59 | 19 | $2,762 |
| Ozempic (Semaglutide) | Brand | 49 | 18 | $83,497 |
| Nano 2Nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 45 | 26 | $5,684 |
| Jardiance (Empagliflozin) | Brand | 44 | 16 | $69,455 |
| Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) | Brand | 38 | 18 | $23,853 |
Hospital affiliations
Frequently asked questions
What is Dr. Kavita Seetharaman's medical specialty?
Dr. Kavita Seetharaman practices Endocrinology, Diabetes & Metabolism Physician in Boston, MA.
Where does Dr. Kavita Seetharaman practice?
Dr. Kavita Seetharaman practices at 75 Francis St, Boston, MA 021156110. Office phone: 6177325500.
What is Dr. Kavita Seetharaman's NPI?
Dr. Kavita Seetharaman's National Provider Identifier (NPI) is 1588608533, issued by NPPES.
Does Dr. Kavita Seetharaman accept Medicare assignment?
Yes. Dr. Kavita Seetharaman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kavita Seetharaman commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); New patient office or other outpatient visit (HCPCS 99204). Source: CMS Medicare Physician & Other Practitioners file.